Merck Sharp and Dohme Corporation v Clonmel Healthcare Ltd

Core Citations

CONSIDERS

• Teva UK Ltd v Gilead Sciences, Inc.
• Merck Sharp & Dohme Corporation v Clonmel Healthcare Ltd
• Generics (UK) Ltd v Daiichi Pharmaceutical Company Ltd (Costs)

[See more]

• Yeda Research and Development Company Ltd v Comptroller General of Patents

CONSIDERS

• Patents Act 1977
• Patents Act 1977
• Patents Act, 1992 - Articles : S-45

[See more]

REFERS TO

• Teva UK Ltd v Gilead Sciences, Inc.
• Yeda Research and Development Company Ltd v Comptroller General of Patents

CITES

• Generics (UK) Ltd v Daiichi Pharmaceutical Company Ltd (Costs)

AFFIRMS

• Merck Sharp & Dohme Corporation v Clonmel Healthcare Ltd

REPORTED OPINION OF in

• [2021] 2 JIC 2402

CONSIDERED in

• Child and Family Agency and Others v Adoption Authority of Ireland and Others
• Merck Sharp & Dohme LLC v Mylan Ire Healthcare Ltd and Mylan Ireland Ltd and McDermott Laboratories T/A as Gerard Laboratories T/A as Mylan Dublin

APPLIED in

• Merck Sharp & Dohme Ltd v Clonmel Healthcare Ltd

This document cites

• Withler v. Canada (Attorney General), [2011] N.R. TBEd. MR.002
• Yeda Research and Development Company Ltd v Comptroller General of Patents
• Generics (UK) Ltd v Daiichi Pharmaceutical Company Ltd (Costs)
• Patents Act 1977
• Merck Sharp & Dohme Corporation v Clonmel Healthcare Ltd



See all quotations

• Teva UK Ltd v Gilead Sciences, Inc.
• Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
• Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (Codified version) (Text with EEA relevance)
• Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products